Literature DB >> 2450346

Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine.

K Higuchi1, A V Hospattankar, S W Law, N Meglin, J Cortright, H B Brewer.   

Abstract

Human apolipoprotein B (apoB) is present in plasma as two separate isoproteins, designated apoB-100 (512 kDa) and apoB-48 (250 kDa). ApoB is encoded by a single gene on chromosome 2, and a single nuclear mRNA is edited and processed into two separate apoB mRNAs. A 14.1-kilobase apoB mRNA codes for apoB-100, and the second mRNA, which codes for apoB-48, contains a premature stop codon generated by a single base substitution of cytosine to uracil at nucleotide 6538, which converts the translated CAA codon coding for the amino acid glutamine at residue 2153 in apoB-100 to a premature in-frame stop codon (UAA). Two 30-base synthetic oligonucleotides (nucleotides 6523-6552 of apoB mRNA), designated apoB-Stop and apoB-Gln, were synthesized containing the complementary sequence to the stop codon (UAA) and glutamine codon (CAA), respectively. Analysis of intestinal apoB mRNA by hybridization with apoB-Stop and apoB-Gln probes and sequence analysis of apoB clones in two independent human small intestinal cDNA libraries established that intestinal apoB mRNA contained both the apoB mRNA that codes for apoB-100 and the apoB mRNA containing the premature in-frame stop codon, which codes for apoB-48. Investigation of hepatic apoB mRNA and two hepatic cDNA libraries by hybridization with the apoB-Stop and apoB-Gln synthetic probes as well as by cDNA sequencing revealed that liver apoB mRNA also contains both the apoB-100 mRNA and the apoB-48 mRNA containing the stop codon. The combined results from these studies establish that both human intestine and liver contain the two distinct apoB mRNAs, an mRNA that codes for apoB-100 and an apoB mRNA that contains the premature stop codon, which codes for apoB-48. The premature in-frame stop codon is not tissue specific and is present in both human liver and intestine.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450346      PMCID: PMC279861          DOI: 10.1073/pnas.85.6.1772

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons.

Authors:  J P Kane; D A Hardman; H E Paulus
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

2.  Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2.

Authors:  S W Law; K J Lackner; A V Hospattankar; J M Anchors; A Y Sakaguchi; S L Naylor; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Presence of B-100 in rat mesenteric chyle.

Authors:  D M Lee; E Koren; S Singh; T Mok
Journal:  Biochem Biophys Res Commun       Date:  1984-09-28       Impact factor: 3.575

4.  Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion.

Authors:  R A Borchardt; R A Davis
Journal:  J Biol Chem       Date:  1987-12-05       Impact factor: 5.157

5.  Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48. Evidence that both apoproteins are products of the same gene.

Authors:  S G Young; S J Bertics; T M Scott; B W Dubois; L K Curtiss; J L Witztum
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

6.  Human ApoB-100 gene resides in the p23----pter region of chromosome 2.

Authors:  S W Law; N Lee; J C Monge; H B Brewer; A Y Sakaguchi; S L Naylor
Journal:  Biochem Biophys Res Commun       Date:  1985-09-16       Impact factor: 3.575

7.  Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat.

Authors:  C E Sparks; O Hnatiuk; J B Marsh
Journal:  Can J Biochem       Date:  1981-08

8.  Apolipoprotein B synthesis by human liver and intestine in vitro.

Authors:  R M Glickman; M Rogers; J N Glickman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

9.  Apolipoprotein B synthesis in humans: liver synthesizes only apolipoprotein B-100.

Authors:  S B Edge; J M Hoeg; P D Schneider; H B Brewer
Journal:  Metabolism       Date:  1985-08       Impact factor: 8.694

10.  Apolipoprotein B is structurally and metabolically heterogeneous in the rat.

Authors:  J Elovson; Y O Huang; N Baker; R Kannan
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

View more
  16 in total

1.  RNA editing of wheat mitochondrial ATP synthase subunit 9: direct protein and cDNA sequencing.

Authors:  D Bégu; P V Graves; C Domec; G Arselin; S Litvak; A Araya
Journal:  Plant Cell       Date:  1990-12       Impact factor: 11.277

2.  Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels.

Authors:  J Coresh; T H Beaty; P O Kwiterovich; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

3.  Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding.

Authors:  J S Cohn; D A Wagner; S D Cohn; J S Millar; E J Schaefer
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

Review 4.  Gene regulation by mRNA editing.

Authors:  J Ashkenas
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

5.  Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.

Authors:  Daniel S Kim; Amber A Burt; Jane E Ranchalis; Ella R Jarvik; Elisabeth A Rosenthal; Thomas S Hatsukami; Clement E Furlong; Gail P Jarvik
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

6.  Expression of apolipoprotein B mRNAs encoding higher- and lower-molecular weight isoproteins in rat liver and intestine.

Authors:  G E Tennyson; C A Sabatos; K Higuchi; N Meglin; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation.

Authors:  M F Linton; R Gish; S T Hubl; E Bütler; C Esquivel; W I Bry; J K Boyles; M R Wardell; S G Young
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

8.  Characterization of single base substitutions in edited apolipoprotein B transcripts.

Authors:  G E Tennyson; C A Sabatos; T L Eggerman; H B Brewer
Journal:  Nucleic Acids Res       Date:  1989-01-25       Impact factor: 16.971

9.  N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes.

Authors:  H Wang; X Chen; E A Fisher
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

Review 10.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.